MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Ultra high field magnetic resonance imaging of nigrosome 1 is a biomarker of new onset and premotor Parkinson’s disease

    M.A. Brodsky, J.M. Pollock, J. Grinstead, D. Lahna, D. Pettersson, W.D. Rooney (Portland, OR, USA)

    Objective: An unmet need exists to develop a methodology to diagnose Parkinson's disease (PD) in the premotor stage, so that patients can be enrolled in…
  • 2016 International Congress

    Intraoperative localization of beta band and high-frequency oscillations within the subthalamic nucleus

    B.C.M. van Wijk, A. Pogosyan, T. Foltynie, M.I. Hariz, P. Limousin, L. Zrinzo, P. Brown, V. Litvak (London, United Kingdom)

    Objective: To investigate whether beta band activity (13-30Hz) and high-frequency oscillations (150-400Hz) arise from the same spatial location within the subthalamic nucleus (STN) of Parkinson's…
  • 2016 International Congress

    The patient’s perspective: The effect of dopamine on Parkinson symptoms

    H. Zach, M.F. Dirkx, J.W. Pasman, B.R. Bloem, R.C. Helmich (Vienna, Austria)

    Objective: To investigate the correlation between patient-based vs. clinician-based L-Dopa effects on PD symptoms in tremor-dominant patients. Background: Medication adjustments are often solely based on…
  • 2016 International Congress

    Detecting brainstem changes in Parkinson’s disease using quantitative MRI

    C. Lambert, A. Lutti, B. Draganski, T. Foltynie (London, United Kingdom)

    Objective: 1. Can brainstem changes be detected using quantitative MRI (qMRI). 2. How many subjects would be required to detecting changes in brainstem regions affected…
  • 2016 International Congress

    Critical path for Parkinson’s II: Global regulatory agencies support the use of dopamine transporter neuroimaging as an enrichment biomarker to enable clinical trials in early Parkinson’s disease

    D.T. Stephenson, S. Arneric, D. Babcock, P. Cole, T. Comery, M.F. Gordon, D. Grosset, D. Hill, S.Z. Imam, C.R. Jarecke, V. Kern, D. Matthews, R. Meibach, K. Romero, A. Roach, D. Russell, J. Seibyl, P. Sherwin, B.A. Sieber, L. Slicker, C. Sur, K. Marek (Tucson, AZ, USA)

    Objective: This presentation focuses on neuroimaging of the Dopamine Transporter as an enrichment biomarker in clinical trials of Parkinson's disease (PD). Background: The Critical Path…
  • 2016 International Congress

    Improvement of saccade amplitude by the STN DBS and visual target eccentricity

    A. Yugeta, Y. Terao, Y. Ugawa (Tokyo, Japan)

    Objective: To investigate whether or not the improvement of saccade amplitude by the subthalamic nucleus (STN) deep brain stimulation (DBS) is the same for to…
  • 2016 International Congress

    Neuromelanin-MRI of substantia nigra subregions in Parkinson’s disease

    L. Borellini, G. Franco, P. Trujillo, P. Summers, A. Di Fonzo, D.O. Claassen, A. Costa (Milan, Italy)

    Objective: To detect changes in the different subregions of the substantia nigra pars compacta (SNc) in patients with Parkinson's disease (PD) and to correlate the…
  • 2016 International Congress

    Spectral analysis of rapid eye movement (REM) sleep as a potential marker of neurodegenerative disease in REM sleep behavior disorder

    J. Rodrigues Brazète, J.F. Gagnon, R.B. Postuma, P.A. Bourgouin, D. Petit, J. Montplaisir (Montreal, QC, Canada)

    Objective: To investigate whether spectral analysis at baseline in rapid eye movement (REM) sleep can differentiate patients with REM sleep behavior disorder (RBD) who will…
  • 2016 International Congress

    Impact of chronic LD treatment on metabolism, blood flow and blood-brain barrier permeability in the 6-OHDA rat model

    R.P. Lerner, Z. Bimpisidis, V. Jourdain, T. Chaly, M. Hellman, K. Graf, V. Dhawan, S. Dewey, A. Cenci, D. Eidelberg (Manhasset, NY, USA)

    Objective: To determine the effects of chronic LD treatment and induction of dyskinesias on cerebral metabolism, blood flow and blood-brain barrier permeability in 6-OHDA rat…
  • 2016 International Congress

    Multi-modal imaging in Parkinson’s disease patients with freezing of gait

    J.M. Hall, C. O'Callaghan, J.M. Shine, M. Gilat, C.C. Walton, K.A. Ehgoetz Martens, A.A. Moustafa, S.J.G. Lewis (Milperra, Australia)

    Objective: The objective of the current study is to refine understanding of the pathophysiological mechanisms underlying freezing of gait (FOG) in Parkinson's disease (PD) using…
  • « Previous Page
  • 1
  • …
  • 1655
  • 1656
  • 1657
  • 1658
  • 1659
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley